Skip to main content
. 2021 Oct 9;21:359. doi: 10.1186/s12893-021-01363-4

Table 2.

Univariate and multivariate analyses of intrahepatic cholangiocarcinoma

OS DFS
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
HR P HR P HR P HR P
LND
No 1  < 0.01 1 0.71 1  < 0.01 1 0.22
Yes 1.751 (1.157–2.650) 0.909 (0.548–1.508) 1.896 (1.259–2.857) 1.357 (0.838–2.197)
Sex
Female 1 0.91 1 0.94
Male 1.021 (0.728–1.431) 1.013 (0.734–1.397)
Age (year)
 ≤ 60 1 0.44 1 0.33
 > 60 0.873 (0.619–1.230) 0.850 (0.613–1.179)
POD time (day)
 ≤ 9 1  < 0.01 1 0.24 1 0.057 1 0.37
 > 9 2.050 (1.447–2.906) 1.299 (0.836–2.019) 1.369 (0.990–1.893) 1.215 (0.795–1.858)
HbsAg + 
No 1 0.45 1 0.49
Yes 0.839 (0.530–1.329) 1.151 (0.770–1.722)
CEA (ng/mL)
 ≤ 7 1  < 0.01 1  < 0.01 1  < 0.01 1 0.04
 > 7 3.801 (2.526–5.718) 2.117 (1.288–3.480) 2.461 (1.623–3.731) 1.677 (1.035–2.716
CA199 (U/mL)
 ≤ 75 1  < 0.01 1 0.03 1  < 0.01 1 0.13
 > 75 2.421 (1.691–3.465) 1.565 (1.044–2.346) 1.877 (1.339–2.631) 1.355 (0.918–2.001)
Operation time (min)
 ≤ 235 1  < 0.01 1 0.07 1  < 0.01 1 0.37
 > 235 2.148 (1.523–3.029) 1.529 (0.974–2.398) 1.661 (1.200–2.299) 1.210 (0.797–1.836)
Blood loss (mL)
 ≤ 300 1  < 0.01 1 0.48 1  < 0.01 1 0.64
 > 300 2.058 (1.465–2.891) 1.207 (0.719–2.026) 1.541 (1.116–2.126) 1.103 (0.728–1.673)
Intraoperative blood transform
No 1  < 0.01 1 0.37 1 0.26
Yes 1.944 (1.381–2.735) 0.760 (0.419–1.379) 1.215 (0.869–1.699)
Tumor size (cm)
 ≤ 6 1 0.03 1 0.09 1 0.04 1 0.18
 > 6 1.454 (1.038–2.036) 1.408 (0.949–2.088) 1.405 (1.018–1.938) 1.275 (0.893–1.819)
Multi-disease
No 1  < 0.01 1 0.15 1  < 0.01 1 0.12
Yes 2.017 (1.361–2.989) 1.467 (0.868–2.481) 1.809 (1.215–2.692) 1.507 (0.903–2.516)
Margin + 
No 1  < 0.01 1  < 0.01 1  < 0.01 1 0.10
Yes 2.566 (1.588–4.148) 2.908 (1.642–5.152) 1.977 (1.229–3.181) 1.617 (0.916–2.855)
Differentiation
Moderately + well 1 1 1
Poorly 1.096 (0.775–1.550) 0.61 1.438 (1.039–1.989) 0.03 1.583 (1.071–2.341) 0.02
Vascular invasion
No 1 0.01 1 0.56 1  < 0.01 1 0.70
Yes 1.891 (1.350–2.650) 1.146 (0.728–1.802) 1.642 (1.189–2.267) 1.090 (0.710–1.674)
Nerve invasion
No 1  < 0.01 1 0.16 1  < 0.01 1 0.12
Yes 1.808 (1.259–2.599) 1.387 (0.877–2.194) 1.747 (1.240–2.461) 1.340 (0.874–2.054)
T state
T1 1  < 0.01 1 0.03 1  < 0.01 1 0.78
 > T1 2.494 (1.776–3.504) 1.747 (1.071–2.848) 1.652 (1.185–2.302) 0.936 (0.594–1.476)
Adjuvant chemotherapy
No 1 0.09 1 0.78
Yes 0.741 (0.526–1.044) 0.953 (0.683–1.331)
ASA
 ≤ 2 1 0.60 1 0.70
 > 2 0.849 (0.458–1.574) 1.113 (0.641–1.932)
BMI (kg/m2)
 < 25 1 0.78 1 0.75
 ≥ 25 1.050 (0.748–1.474) 0.948 (0.685–1.311)
Cirrhosis
No 1 0.14 1
Yes 1.423 (0.893–2.268) 0.884 (0.592–1.320)
Comorbidity
No 1 0.16 1 0.99
Yes 0.780 (0.554–1.098) 1.003 (0.726–1.384)
ALT (U/L)
 ≤ 50 1  < 0.01 1 0.91 1 0.94
 > 50 2.049 (1.379–3.045) 1.034 (0.578–1.850) 0.984 (0.634–1.526)
TBIL (ALB)
1 0.05 1 0.95 1 0.54
1.526 (1.006–2.313) 1.020 (0.571–1.821) 0.865 (0.545–1.372)
ALB (g/L)
 ≥ 35 1  < 0.01 1 0.19 1 0.93
 < 35 2.458 (1.450–4.168) 1.628 (0.791–3.354) 0.970 (0.509–1.846)

Bold means P was less than or equal to 0.05